封面
市场调查报告书
商品编码
1789390

显影剂

Contrast Media Market, By Type, By Imaging Technique, By Application, By Route of Administration, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

显影剂市场规模预计在 2025 年为 63.5 亿美元,预计到 2032 年将达到 109.5 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 8.1%。

分析范围 分析详细信息
基准年 2024 市场规模(2025年) 63.5亿美元
效能数据 2020-2024 预测期 2025-2032
预测期间的复合年增长率(2025-2032年) 8.10% 预计金额(2032年) 109.5亿美元

全球显影剂市场是医学影像产业的重要组成部分,涵盖旨在增强诊断影像过程中体内结构可见度的专用药剂。这些显影剂(也称为造影染料)用于患者接受各种影像检查,包括电脑断层扫描 (CT)、超音波磁振造影(MRI)、超音波和 X 光,以提高诊断准确性和临床疗效。

市面上的显影剂种类繁多,包括碘基显影剂、钆基显影剂、钡基化合物和微气泡造影显影剂,每种造影剂都是针对特定的成像应用和患者要求量身定制的。由于慢性病的增加、人口老化以及医学影像设备的技术进步,全球对先进显影剂解决方案的需求持续成长。在提高诊断准确性同时最大限度地减少副作用的需求的推动下,市场的特点是配方化学、安全性和有针对性的成像应用不断创新。市场参与企业正专注于开发具有改进的生物相容性、降低的肾毒性和增强的影像处理能力的下一代显影剂,以满足全球不同医疗环境中不断变化的临床需求和监管标准。

市场动态

全球显影剂市场的成长受到若干关键因素的驱动,这些因素推动了国际医疗保健体系的持续成长。心血管、癌症和神经系统疾病的盛行率不断上升,对先进的诊断影像技术提出了更高的要求,从而推动了对能够精确显示解剖结构和病理的高品质显影剂的需求。医疗影像设备的技术进步,例如高解析度CT扫描仪、先进的MRI系统和高性能超音波设备的开发,为增强显影剂创造了机会,使其能够充分利用改进的诊断成像能力。

全球人口老化是主要的成长动力,因为老年患者需要更频繁地进行影像学检查以管理慢性病和预防性医疗保健/筛检计画。然而,市场面临重大限制因素,例如严格的监管核准流程,这延迟了产品上市并增加了开发成本,尤其是对于需要大量临床试验和安全评估的新型显影剂配方。由于担心某些显影剂会引起显影剂诱发的肾臟病、过敏反应和肾源性系统性纤维化等安全问题,医疗专业人员和患者对某些造影剂的采用模式持谨慎态度,对市场扩张构成了挑战。儘管存在这些限制因素,但新兴经济体医疗基础设施的扩大、医疗支出的增加、早期疾病检测意识的提高以及提供有针对性成像解决方案的器官特异性显影剂的开发,正在涌现出巨大的商机。

本报告的主要特点

  • 本报告对全球显影剂市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还强调了每个领域的潜在商机,并描述了该市场的一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球显影剂市场的主要企业已根据以下参数进行分析,例如公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 「全球显影剂市场」报告涉及该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球显影剂市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章:市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特五力分析
  • 企业合併(M&A)场景
  • 产业趋势

第四章。全球显影剂市场按类型(以金额为准,2020-2032)

  • 碘基显影剂
  • 单体碘显影剂
  • 二聚碘显影剂
  • 钆基显影剂(GBCM)
  • 钡基显影剂
  • 其他(微气泡显影剂)

5. 全球显影剂(以金额为准,2020-2032 年)

  • X光/电脑断层扫描(CT)
  • 磁振造影(MRI)
  • 超音波影像
  • 透视
  • 其他(血管造影术)

6. 全球显影剂市场应用(以金额为准,2020-2032)

  • 心血管系统
  • 肿瘤学
  • 神经病学
  • 胃肠道
  • 肌肉骨骼
  • 泌尿系统
  • 感染疾病
  • 其他治疗领域

7. 依给药途径分類的全球显影剂市场(以金额为准,2020-2032 年)

  • 口服
  • 直肠
  • 静脉

8. 全球显影剂(以金额为准,2020-2032)

  • 医院
  • 诊断中心
  • 影像中心
  • 门诊手术中心
  • 其他(研究和学术机构)

9. 全球显影剂市场按地区(以金额为准,2020-2032)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十章 竞争格局

  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN(Medtronic)
  • Esaote SpA
  • Shimadzu Corporation
  • Hughes Medical Systems

第 11 章分析师建议

  • “命运之轮”
  • 分析师观点
  • Coherent Opportunity Map (COM)

第十二章参考文献与调查方法

  • 参考
  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI8350

Contrast Media Market is estimated to be valued at USD 6.35 Bn in 2025 and is expected to reach USD 10.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.35 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.10% 2032 Value Projection: USD 10.95 Bn

The global contrast media market represents a critical segment within the broader medical imaging industry, encompassing specialized pharmaceutical agents designed to enhance the visibility of internal body structures during diagnostic imaging procedures. These contrast agents, also known as contrast materials or contrast dyes, are administered to patients undergoing various imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray examinations to improve diagnostic accuracy and clinical outcomes.

The market comprises different types of contrast media, including iodinated contrast agents, gadolinium-based contrast agents, barium-based compounds, and microbubble contrast agents, each tailored for specific imaging applications and patient requirements. With the increasing prevalence of chronic diseases, aging population demographics, and technological advancements in medical imaging equipment, the demand for sophisticated contrast media solutions continues to expand globally. The market is characterized by continuous innovation in formulation chemistry, safety profiles, and targeted imaging applications, driven by the need for enhanced diagnostic precision while minimizing adverse reactions. Key market participants focus on developing next-generation contrast agents with improved biocompatibility, reduced nephrotoxicity, and enhanced imaging capabilities to meet evolving clinical demands and regulatory standards across diverse healthcare settings worldwide.

Market Dynamics

The global contrast media market growth is primarily driven by several key factors that collectively fuel its sustained growth trajectory across international healthcare systems. The increasing incidence of cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic imaging procedures, thereby boosting demand for high-quality contrast agents that enable precise visualization of anatomical structures and pathological conditions. Technological advancements in medical imaging equipment, including the development of high-resolution CT scanners, advanced MRI systems, and sophisticated ultrasound devices, create opportunities for enhanced contrast media formulations that can capitalize on improved imaging capabilities.

The aging global population represents a significant growth driver, as elderly patients require more frequent diagnostic imaging procedures for chronic disease management and preventive healthcare screening programs. However, the market faces notable restraints including stringent regulatory approval processes that can delay product launches and increase development costs, particularly for novel contrast agent formulations requiring extensive clinical trials and safety evaluations. Safety concerns related to contrast-induced nephropathy, allergic reactions, and nephrogenic systemic fibrosis associated with certain contrast agents pose challenges for market expansion, leading to cautious adoption patterns among healthcare providers and patients. Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, growing awareness about early disease detection, and the development of organ-specific contrast agents that offer targeted imaging solutions.

Key Features of the Study

  • This report provides an in-depth analysis of the global contrast media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global contrast media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Bayer AG, Bracco Imaging, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, Guerbet Group, Mallinckrodt Pharmaceuticals, Canon Medical Systems, Hologic, Inc., Lantheus Medical Imaging, COVIDIEN (Medtronic), Esaote S.p.A., Shimadzu Corporation, and Hughes Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contrast media market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Iodinated Contrast Media
    • Monomeric Iodinated Contrast Media
    • Dimeric Iodinated Contrast Media
    • Gadolinium-Based Contrast Media (GBCM)
    • Barium-Based Contrast Media
    • Others (Microbubble Contrast Media)
  • Imaging Technique Insights (Revenue, USD Bn, 2020 - 2032)
    • X-ray/Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound Imaging
    • Fluoroscopy
    • Others (Angiography)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cardiovascular
    • Oncology
    • Neurology
    • Gastrointestinal
    • Musculoskeletal
    • Pulmonary
    • Urology
    • Infectious Diseases
    • Other Therapeutic Areas
  • Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Rectal
    • Intravenous
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Imaging Centers
    • Ambulatory Surgical Centers
    • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Bayer AG
    • Bracco Imaging
    • Siemens Healthineers
    • Fujifilm Holdings Corporation
    • Philips Healthcare
    • Guerbet Group
    • Mallinckrodt Pharmaceuticals
    • Canon Medical Systems
    • Hologic, Inc.
    • Lantheus Medical Imaging
    • COVIDIEN (Medtronic)
    • Esaote S.p.A.
    • Shimadzu Corporation
    • Hughes Medical Systems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contrast Media Market, By Type
    • Global Contrast Media Market, By Imaging Technique
    • Global Contrast Media Market, By Application
    • Global Contrast Media Market, By Route of Administration
    • Global Contrast Media Market, By End User
    • Global Contrast Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contrast Media Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Monomeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dimeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gadolinium-Based Contrast Media (GBCM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Barium-Based Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Microbubble Contrast Media)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contrast Media Market, By Imaging Technique, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • X-ray/Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ultrasound Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fluoroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Angiography)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contrast Media Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contrast Media Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Contrast Media Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Contrast Media Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bracco Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Guerbet Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • COVIDIEN (Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Esaote S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hughes Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us